Fonte: Clinical research in cardiology. Unidade: FM
Assuntos: CONTENEDORES, INFARTO DO MIOCÁRDIO, CORONARIOPATIA, ANTIBIÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
IKEOKA, Dimas T. et al. Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation occurring after coronary stenting. Clinical research in cardiology, v. 98, p. 44-51, 2009Tradução . . Disponível em: https://doi.org/10.1007/s00392-008-0722-1. Acesso em: 15 jun. 2024.APA
Ikeoka, D. T., Vieira, C. Z., Lemos, P. A., Strabelli, T. V., Silva, E. E. R., Perin, M. A., et al. (2009). Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation occurring after coronary stenting. Clinical research in cardiology, 98, 44-51. doi:10.1007/s00392-008-0722-1NLM
Ikeoka DT, Vieira CZ, Lemos PA, Strabelli TV, Silva EER, Perin MA, Groselj-Strele A, Tiran B, Tiran A, Caramelli B. Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation occurring after coronary stenting [Internet]. Clinical research in cardiology. 2009 ; 98 44-51.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1007/s00392-008-0722-1Vancouver
Ikeoka DT, Vieira CZ, Lemos PA, Strabelli TV, Silva EER, Perin MA, Groselj-Strele A, Tiran B, Tiran A, Caramelli B. Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation occurring after coronary stenting [Internet]. Clinical research in cardiology. 2009 ; 98 44-51.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1007/s00392-008-0722-1
